Full-Time

Senior Manager

Clinical Product Communications & Operations

Posted on 4/4/2026

Deadline 5/29/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$118.5k - $284.3k/yr

+ Bonus + Commission + Equity Grants

Company Historically Provides H1B Sponsorship

Smithfield, RI, USA + 5 more

More locations: Chicago, IL, USA | Needham, MA, USA | Scottsdale, AZ, USA | Hartford, CT, USA | Irving, TX, USA

In Person

Category
Product (1)
Required Skills
UI/UX Design
Product Management
Requirements
  • 8+ years of experience in product operations, product management, portfolio management, or strategy within healthcare, technology, or regulated environments
Responsibilities
  • Executive Communications, Narrative & Leadership Alignment: Serve as the central integrator and communicator of Clinical Product Management performance, maturity, and portfolio health for senior leadership.
  • Executive Communications, Narrative & Leadership Alignment: Translate complex product, platform, and technical information into clear, leadership‑ready narratives focused on outcomes, risks, tradeoffs, and decisions.
  • Executive Communications, Narrative & Leadership Alignment: Own the regular communication and reporting of Clinical Product OKR progress, outcomes, and risks to Product and Technology leadership, ensuring updates are concise, consistent, and decision‑ready.
  • Executive Communications, Narrative & Leadership Alignment: Support leadership‑facing materials including business reviews, roadmap forums, OKR readouts, operating reviews, and select enterprise or Board‑level updates as part of broader product governance and accountability.
  • OKR Strategy, Alignment & Operating Discipline: Lead the identification, alignment, and ongoing tracking of Clinical Product Management OKRs in partnership with Product, Technology, and the Product Office.
  • OKR Strategy, Alignment & Operating Discipline: Ensure OKRs are outcome‑oriented, measurable, and clearly linked to enterprise strategy, clinical priorities, and platform‑level execution.
  • OKR Strategy, Alignment & Operating Discipline: Establish standardized artifacts, cadences, and narratives for OKR reviews, health checks, and performance discussions.
  • OKR Strategy, Alignment & Operating Discipline: Establish and sustain operating rhythms that support consistent planning, performance review, and portfolio optimization across Clinical Product teams.
  • Product Maturity, Governance & Portfolio Visibility: In close collaboration with the Product Office, own the definition, tracking, and communication of Clinical Product Maturity Scorecards, providing leadership visibility across dimensions such as outcomes, usability, UX, scalability, technical health, and operational readiness.
  • Product Maturity, Governance & Portfolio Visibility: Establish and evolve product governance frameworks in close partnership with the Product Office to drive consistency, accountability, and product excellence.
  • Product Maturity, Governance & Portfolio Visibility: Use insights from OKRs, maturity assessments, and delivery performance to inform continuous improvement and optimization opportunities across the portfolio.
  • Cross‑Functional Integration & Execution Enablement: In close collaboration with the Product Office, partner with Product and Engineering Leads to align prioritization approaches, scoring models, and decision frameworks across Clinical Product teams.
  • Cross‑Functional Integration & Execution Enablement: Support roadmap management practices by ensuring roadmaps are outcome‑driven, maturity‑informed, and aligned across platforms and delivery teams.
  • Cross‑Functional Integration & Execution Enablement: Serve as a designated point of contact beyond Product, integrating inputs from Engineering, Delivery, UX, and the COE into a unified leadership narrative.
  • UX, Innovation & Ways of Working: Partner with UX, Product, and COE leaders to reinforce member‑ and clinician‑centered design principles, ensuring UX imperatives are embedded, measured, and communicated.
  • UX, Innovation & Ways of Working: Enable structured innovation approaches, including experimentation, learning cycles, and evaluation of new product concepts.
  • UX, Innovation & Ways of Working: Develop and maintain playbooks, templates, and guidance that define standard ways of working across product operations, OKRs, maturity, and governance.
  • UX, Innovation & Ways of Working: Partner with the Product Office to design and deliver training and enablement materials that strengthen product management capability and operational maturity.
Desired Qualifications
  • Demonstrated experience owning OKR processes, performance communication, and portfolio-level reporting
  • Proven ability to partner effectively with a Product Office or similar centralized product governance function
  • Strong ability to influence cross-functional leaders and drive alignment in a matrixed organization

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue exceeded $100B, up 6% year-over-year.
  • Medical benefit ratio improved to 84.6%, signaling better cost management.
  • Pharmacy-only locations in underserved areas drive medication access expansion.

What critics are saying

  • Amazon Pharmacy captures 20% urban market share with next-day delivery.
  • FTC settlement forces PBM margin cuts of 15-20% through transparency.
  • State-level spread pricing bans eliminate $2-3B annual pharmacy revenue.

What makes CVS Health unique

  • Integrated model combines insurance, pharmacy, and primary care clinics uniquely.
  • Over 800 MinuteClinic locations and 24/7 virtual care nationwide.
  • Aetna serves 26 million medical members with broad health plans.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

PR Newswire
Mar 30th, 2026
CVS opens first pharmacy-only location in Chicago, plans nearly 20 this year

CVS Health has opened its first pharmacy-only location in Chicago, part of plans to launch nearly 20 such sites across the US this year. The 3,000-square-foot store at 2628 West Pershing Road features a full-service pharmacy with selected over-the-counter products. The pharmacy-only format is designed to increase access to medications, immunizations and pharmacist consultations in underserved communities. Additional locations are planned for Houston, Roxbury, Detroit and Brooklyn in 2026, alongside more than 40 traditional CVS Pharmacy stores. The move responds to consumer preferences, with CVS's 2025 research showing 80% of patients prefer face-to-face pharmacy care and 48% would switch pharmacies if limited to digital-only options. The company opened its first pharmacy-only site in Birmingham, Alabama, late last year.

Yahoo Finance
Mar 26th, 2026
CVS settles FTC insulin pricing probe as regulatory scrutiny of pharmacy benefit manager intensifies

CVS Health has reached a proposed settlement with the Federal Trade Commission over insulin pricing practices at its Caremark pharmacy benefit manager unit. The company also declared a quarterly dividend of $0.665 per share, payable on 4 May 2026. The settlement places CVS's pharmacy benefit management model under increased regulatory scrutiny regarding drug cost transparency. The company's investment narrative centres on its integrated model across insurance, pharmacy and care delivery, with near-term focus on restoring profitability in healthcare delivery and PBM services. CVS recently appointed former Elevance Health CFO John E. Gallina to its board as an audit committee financial expert. The company's narrative projects $445.5 billion revenue and $10.2 billion earnings by 2029, implying a fair value of $96.50 per share.

Yahoo Finance
Mar 23rd, 2026
Bernstein upgrades CVS Health to Outperform with $94 price target amid Medicare Advantage turnaround

Bernstein analyst Lance Wilkes upgraded CVS Health to "Outperform" from "Market Perform" on 12 March, raising the price target to $94 from $91. The upgrade reflects the company's attractive exposure to the Medicare Advantage turnaround and expectations of stable earnings in its pharmacy and pharmacy benefit manager businesses following reforms. Wilkes cited the PBM bill passage and the Federal Trade Commission settlement with Cigna as clearing events for the stock. Separately, CVS Health announced a strategic partnership with Google Cloud focused on reimagining healthcare experiences through its new health technology subsidiary, Health100, which will offer AI-powered healthcare services. CVS Health operates as a diversified healthcare company combining insurance, pharmacy benefit management, retail pharmacies and clinical services across the United States.

Yahoo Finance
Mar 13th, 2026
CVS Health's Aetna unit pays $117.7M to settle Medicare Advantage fraud allegations

Aetna, a CVS Health subsidiary, has agreed to pay $117.7 million to the US Department of Justice to settle allegations that it submitted inaccurate diagnosis codes for Medicare Advantage members to increase reimbursements. The settlement resolves longstanding False Claims Act allegations related to the Medicare Advantage programme. CVS Health shares recently closed at $76.07, down 5.1% year-to-date, though up 20.1% over the past year. The settlement is material for the company, which has thin net margins of 0.4% and debt not well covered by operating cash flow. The agreement highlights compliance risks in CVS Health's government-facing insurance operations, a central part of its Medicare Advantage business. Analysts' average target price stands at $96.50, approximately 27% above current levels.

Yahoo Finance
Mar 7th, 2026
Alphabet faces wrongful death lawsuit over Gemini AI chatbot while expanding healthcare partnership with CVS

Alphabet faces a wrongful death lawsuit alleging its Gemini AI chatbot contributed to a user's suicide, reportedly the first legal case directly linking Google's AI tools to a death. Simultaneously, the company announced a healthcare AI partnership with CVS Health focused on a real-time consumer engagement platform. The contrasting developments underscore Alphabet's expanding role in high-stakes sectors. The CVS collaboration integrates Gemini into Health100, a platform handling personal interactions across insurers, pharmacies and care providers. Meanwhile, the lawsuit tests whether conversational AI design and crisis protocols carry a duty of care, even outside formal healthcare settings. For investors, the key questions centre on how Alphabet manages legal risk, establishes guardrails and navigates regulatory oversight as its AI tools penetrate sectors requiring heightened safety and compliance standards.

INACTIVE